Replies to Post #53868 onNorthWest Biotherapeutics Inc (NWBO)

Replies to post #53868 on NorthWest Biotherapeutics Inc (NWBO)

Replies to #53868 on NorthWest Biotherapeutics Inc (NWBO)

02/15/16 10:03 AM

#53872 RE: Rkmatters #53868

Nope discussed here long ago:

Pretty sure it was new news. -Rk

02/15/16 10:06 AM

#53873 RE: Rkmatters #53868

RevImmune is not new news. It has been out there since at least October.

02/15/16 10:20 AM

#53877 RE: Rkmatters #53868

Correction. It should read Group A GTR patient survival range of 18-101 months with changes to Stupp.

Go Ad-Free